Back
Alpha Teknova
IPOTKNO.NASDAQPast

Alpha Teknova

Biotechnology company

Company website
Foundation year: 1996
Profitability
+46.25%
IPO date
6/24/2021

About

Teknova provides critical reagents for bioprocessing, bioproduction, and molecular diagnostics. We support customers in the research, clinical, and applied markets with standard catalog offerings and custom GMP products, including cell culture media and supplements, protein and nucleic acid purification buffers, and molecular biology reagents.

Focusing on agility and customer satisfaction, we strive to meet complex formulation and packaging requirements as well as provide fast turnaround for custom GMP products. As a partner to the biopharma sector, our R&D team offers expertise from prototype product design to guidance on GMP manufacturing of media, buffers, and reagents for the entire cell and gene therapy production workflow.


Number of employees

100-250


Headquarters

Hollister, California, United States

logo
+992 918 138 895

Calls within Tajikistan are free

App Store
Google Play
Feedback form

The information provided is for informational purposes only and should not be considered as an offer to buy or sell foreign currency, securities and/or other financial instruments. The information presented on this website is not an individual investment recommendation. Financial instruments or transactions mentioned in this section may not be suitable for you, may not correspond to your investment profile, financial situation, investment experience, knowledge, investment objectives, attitude to risk and profitability.

LLC "Exchange Broker" does not guarantee and does not promise future profitability of investments, does not guarantee the reliability of possible investments and the stability of possible income. Investment results in the past do not guarantee income in the future.

LLC "Exchange Broker" is not responsible for possible investor losses in the event of transactions and investments in financial instruments, and also does not guarantee the return, effectiveness and profitability of investments.

LLC "Exchange Broker" hereby informs that it operates in the securities market in accordance with the following professional participant licenses issued by the Ministry of Finance of the Republic of Tajikistan: depository activity No.010/25 dated 25.06.2025; brokerage activity No.007/25 dated 25.06.2025; dealer activity No.008/25 dated 25.06.2025 and securities management activity No.009/25 dated 25.06.2025, and also informs about the risk of a conflict of interest, including as a result of combining various types of professional activity in the securities market.